To The Moon

It’s a key week in Earnings Season as many companies released their reports. Some companies experienced roller coaster ride after the earnings release. You can find the stocks that rose or fell most in "Movers & Shakers" on Tiger Trade app. In this article, we gonna brief two companies that beat expectations and one company fell short. 1. $Abbott Laboratories(ABT)$ up 7.82% with better-than-expected earnings and revenues Abbott exited the first quarter of 2023 with better-than-expected earnings and revenues. However, the figures declined on a year-over-year basis. Total sales in the first quarter were negatively impacted by a year-over-year decline in COVID testing-related sales. EPS: $1.03 vs. 99 cents expected Sales: $9.75 bln vs. $9.67 bln expected Gross profit in the reported quarter fell 21.6% year over year to $5.42 billion. Gross margin contracted 251 basis points (bps) to 55.6%. Analysts’ ratings: 24 analysts gave an average rating for $Abbott Laboratories(ABT)$ of $122.16. 2. $Calix(CALX)$ up 11% after the bell The company has topped consensus revenue estimates four times over the last four quarters. EPS: $0.31 beating estimate of $0.29 Revenues: $250.01 mln surpassing the estimate by 1.95% Calix management provided guidance for Q2 2023, expecting earnings between $0.28 and $0.34 per share. Analysts’ ratings: 9 analysts gave an average rating for $Calix(CALX)$ of $182.56 3. $Zions(ZION)$ dropped 4% after its deposits fell short $Zions(ZION)$ stock retreated more than 4% after hours following earnings. In comparison, its shares closed up 7.4%, at 32.72, ahead of the report. The stock price nearly halved during its March plummet and is trading close to two-year lows. EPS:$1.33 vs. $1.53 Revenue: $830 mln vs. $845 mln expected. Deposits fell to $69.2 billion for the quarter, down 3.3% from Q4 and 16% from last year. Analysts predicted deposits would slide to $69.5 billion. Zions' deposits, excluding brokered deposits, were 18% greater than pre-pandemic levels in Q4 2019, CEO Harris Simmons noted. Outlook: Experts forecast Zions full year adjusted earnings ticking up 1% to $5.85 per share on 6% revenue growth to $3.34 billion. Analysts’ ratings: 22 analysts gave an average rating for $Zions(ZION)$ of $40.47